➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
AstraZeneca
Boehringer Ingelheim
Dow
McKinsey
McKesson

Last Updated: May 14, 2021

DrugPatentWatch Database Preview

Drug Price Trends for ORILISSA

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Drug Price Trends for ORILISSA

Average Pharmacy Cost for ORILISSA

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
ORILISSA 150 MG TABLET 00074-0038-28 33.46373 EACH 2021-01-01
ORILISSA 200 MG TABLET 00074-0039-56 16.73097 EACH 2021-01-01
ORILISSA 150 MG TABLET 00074-0038-28 31.15804 EACH 2020-10-21
ORILISSA 200 MG TABLET 00074-0039-56 15.57819 EACH 2020-06-17
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for ORILISSA

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
ORILISSA 200MG TAB Abbvie US LLC 00074-0039-56 4X14 623.17 2020-01-01 - 2023-08-31 Big4
ORILISSA 150MG TAB Abbvie US LLC 00074-0038-28 4X7 632.42 2018-09-11 - 2023-08-31 FSS
ORILISSA 200MG TAB Abbvie US LLC 00074-0039-56 4X14 696.27 2020-01-01 - 2023-08-31 FSS
ORILISSA 150MG TAB Abbvie US LLC 00074-0038-28 4X7 696.27 2019-02-05 - 2023-08-31 FSS
ORILISSA 200MG TAB Abbvie US LLC 00074-0039-56 4X14 607.38 2021-01-01 - 2023-08-31 Big4
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Moodys
McKinsey
Colorcon
Express Scripts
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.